95 related articles for article (PubMed ID: 6214643)
1. The role of routine followup bone scans after definitive therapy of localized prostatic cancer.
Huben RP; Schellhammer PF
J Urol; 1982 Sep; 128(3):510-2. PubMed ID: 6214643
[TBL] [Abstract][Full Text] [Related]
2. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
3. The bone scan as a tumour marker in prostatic carcinoma.
Chisholm GD; Stone AR; Beynon LL; Merrick MV
Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of a bone imaging agent in liver metastases from prostate carcinoma.
Haseman MK
Clin Nucl Med; 1983 Oct; 8(10):488-9. PubMed ID: 6228362
[TBL] [Abstract][Full Text] [Related]
5. The benefits of combining early radionuclide renal scintigraphy with routine bone scans in patients with prostate cancer.
Narayan P; Lillian D; Hellstrom W; Hedgcock M; Jajodia PB; Tanagho EA
J Urol; 1988 Dec; 140(6):1448-51. PubMed ID: 3057227
[TBL] [Abstract][Full Text] [Related]
6. Computerized bone scan. A potentially useful technique to measure response in prostatic carcinoma.
Drelichman A; Decker DA; Al-Sarraf M; Vaitkevicius VK; Muz J
Cancer; 1984 Mar; 53(5):1061-5. PubMed ID: 6229325
[TBL] [Abstract][Full Text] [Related]
7. Preliminary observations on the results of combined 125iodine seed implantation and external irradiation for carcinoma of the prostate.
Ross G; Borkon WD; Landry LJ; Edwards FM; Weinstein SH; Abadir R
J Urol; 1982 Apr; 127(4):699-701. PubMed ID: 7069833
[TBL] [Abstract][Full Text] [Related]
8. How significant are serial bone scans in monitoring advanced prostatic cancer?
Tekgül S; Ozen H; Ozyavuz R; Bakkaloğlu M; Remzi D
Int Urol Nephrol; 1995; 27(1):87-91. PubMed ID: 7615375
[TBL] [Abstract][Full Text] [Related]
9. Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy.
Schellhammer PF; el-Mahdi AM; Higgins EM; Schultheiss TE; Ladaga LE; Babb TJ
J Urol; 1987 May; 137(5):897-901. PubMed ID: 3106654
[TBL] [Abstract][Full Text] [Related]
10. Morbidity and mortality of local failure after definitive therapy for prostate cancer.
Schellhammer PF; Whitmore RB; Kuban DA; el-Mahdi AM; Ladaga LA
J Urol; 1989 Mar; 141(3):567-71. PubMed ID: 2918594
[TBL] [Abstract][Full Text] [Related]
11. [Local findings of renal cell carcinoma on 99m-Tc-DMSA renal, 99m-Tc-MDP bone and 67-Ga-citrate scintigraphies].
Kawamura J; Itoh H; Yoshida O; Fujita T; Fukunaga M; Morita R; Torizuka K
Kaku Igaku; 1982 Apr; 19(3):357-68. PubMed ID: 6290720
[No Abstract] [Full Text] [Related]
12. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
Chybowski FM; Keller JJ; Bergstralh EJ; Oesterling JE
J Urol; 1991 Feb; 145(2):313-8. PubMed ID: 1703240
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of follow-up bone scans in carcinoma of the prostate.
Corrie D; Timmons JH; Bauman JM; Thompson IM
Cancer; 1988 Jun; 61(12):2453-4. PubMed ID: 3130180
[TBL] [Abstract][Full Text] [Related]
14. [Bone scintigraphy showing abnormal diffuse accumulation of the isotope].
Fukuda T; Ochi H; Inoue Y; Onoyama Y
Rinsho Hoshasen; 1981 Jan; 26(1):173-4. PubMed ID: 6452548
[No Abstract] [Full Text] [Related]
15. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
[TBL] [Abstract][Full Text] [Related]
16. [Bone scintigraphy with 99mTc-hydroxymethylene diphosphonate (HMDP)--comparison with 99mtc-MDP (author's transl)].
Nakano S; Hasegawa Y; Shiomura K; Ibuka K; Hashizume T
Kaku Igaku; 1981 Dec; 18(10):1485-8. PubMed ID: 6210789
[No Abstract] [Full Text] [Related]
17. Prostatic metastases versus polycythemia on bone imaging.
Birchall JD; O'Connor RA
Clin Nucl Med; 2004 Jun; 29(6):375-7. PubMed ID: 15166887
[No Abstract] [Full Text] [Related]
18. Serum osteocalcin measurements in prostate carcinoma patients with skeletal deposits shown by bone scintigram: comparison with serum PSA/PAP measurements.
Shih WJ; Wierzbinski B; Collins J; Magoun S; Chen IW; Ryo UY
J Nucl Med; 1990 Sep; 31(9):1486-9. PubMed ID: 1697617
[TBL] [Abstract][Full Text] [Related]
19. Quantitative bone scan and bone metastases in prostatic cancer.
Grob JC; Thiel J; Méthlin G; Wolf P; Bollack C
Urol Int; 1985; 40(1):45-7. PubMed ID: 3156441
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma of the prostate presenting as a single focus of radionuclide accumulation in the mandible on bone and gallium images.
Ackerman L; Reyes CV; Shirazi P; Bushnell D
Clin Nucl Med; 1989 Jul; 14(7):542-3. PubMed ID: 2766639
[No Abstract] [Full Text] [Related]
[Next] [New Search]
